Sphera Funds Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Sphera Funds Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-186,800	Closed	-$549K	–	122
2016 Q1	$549K	Sell	186,800 -363,200	-66%	-$1.04M	0.12%	85
2015 Q4	$1.72M	Buy	550,000 +50,000	+10%	+$171K	0.25%	92
2015 Q3	$1.58M	Buy	+500,000	New	+$1.92M	0.2%	107
2015 Q2	–	Sell	-321,254	Closed	-$1.51M	–	175
2015 Q1	$1.51M	Sell	321,254 -100,000	-24%	-$576K	0.16%	121
2014 Q4	$2.68M	Buy	421,254 +100,000	+31%	+$585K	0.46%	75
2014 Q3	$1.57M	Buy	321,254 +194,206	+153%	+$1.12M	0.19%	102
2014 Q2	$971K	Buy	127,048 +5,900	+5%	+$47K	0.24%	78
2014 Q1	$1.28M	Buy	121,148 +106,267	+714%	+$1.52M	0.29%	73
2013 Q4	$193K	Buy	+14,881	New	+$139K	0.05%	95

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sphera Funds Management's OCRX Position: Q2 2016 in Review

Sphera Funds Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2016, closing a stake of 186,800 shares — an estimated $549K sold.

Sphera Funds Management first reported a position in OCRX in Q4 2013 and held it in 9 quarters. The position peaked at $2.68M in Q4 2014. 33 funds tracked by Wall St. Rank hold OCRX as of Q2 2016.

Sphera Funds Management reported no remaining Ocera Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Sphera Funds Management sold 186,800 Ocera Therapeutics, Inc. shares in Q2 2016, an estimated $549K.
Sphera Funds Management first reported a position in Ocera Therapeutics, Inc. in Q4 2013 and held it in 9 quarters.
Sphera Funds Management's Ocera Therapeutics, Inc. position peaked at $2.68M in Q4 2014.
33 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2016.

Based on Sphera Funds Management's 13F filing for Q2 2016, filed 10 Aug 2016.